These findings indicate that measurements of serum C2C levels taken before initiating anti-TNF-α therapy and after its initiation may provide additional information regarding the radiographic prognosis of patients with RA that is not provided by successive assessments of disease activity. Here, TNF is linked to rheumatoid arthritis.